These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9811500)
1. Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. Newman KD; Sosnowski DL; Kwon GS; Samuel J J Pharm Sci; 1998 Nov; 87(11):1421-7. PubMed ID: 9811500 [TBL] [Abstract][Full Text] [Related]
2. Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response. Newman KD; Samuel J; Kwon G J Control Release; 1998 Jun; 54(1):49-59. PubMed ID: 9741903 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136 [TBL] [Abstract][Full Text] [Related]
4. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213 [TBL] [Abstract][Full Text] [Related]
5. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946 [TBL] [Abstract][Full Text] [Related]
6. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180 [TBL] [Abstract][Full Text] [Related]
7. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Elamanchili P; Diwan M; Cao M; Samuel J Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402 [TBL] [Abstract][Full Text] [Related]
8. Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses. Barratt-Boyes SM; Vlad A; Finn OJ Clin Cancer Res; 1999 Jul; 5(7):1918-24. PubMed ID: 10430099 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses. Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope. Brooks N; Hsu J; Esparon S; Pouniotis D; Pietersz GA Molecules; 2018 Sep; 23(9):. PubMed ID: 30200528 [TBL] [Abstract][Full Text] [Related]
11. Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses. Lutsiak ME; Kwon GS; Samuel J J Pharm Pharmacol; 2006 Jun; 58(6):739-47. PubMed ID: 16734975 [TBL] [Abstract][Full Text] [Related]
12. Poly(d,l)-lactide-co-glycolide (PLGA) microspheres as immunoadjuvant for Brugia malayi antigens. Saini V; Verma SK; Murthy PK; Kohli D Vaccine; 2013 Aug; 31(38):4183-91. PubMed ID: 23827312 [TBL] [Abstract][Full Text] [Related]
13. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Stivaktakis N; Nikou K; Panagi Z; Beletsi A; Leondiadis L; Avgoustakis K J Biomed Mater Res A; 2005 Jun; 73(3):332-8. PubMed ID: 15793820 [TBL] [Abstract][Full Text] [Related]
14. Eliciting cytotoxic T-lymphocyte responses from synthetic vectors containing one or two epitopes in a C57BL/6 mouse model using peptide-containing biodegradable microspheres and adjuvants. Rubsamen RM; Herst CV; Lloyd PM; Heckerman DE Vaccine; 2014 Jul; 32(33):4111-6. PubMed ID: 24912025 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice. Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628 [TBL] [Abstract][Full Text] [Related]
16. Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Jiang T; Singh B; Li HS; Kim YK; Kang SK; Nah JW; Choi YJ; Cho CS Biomaterials; 2014 Feb; 35(7):2365-73. PubMed ID: 24342722 [TBL] [Abstract][Full Text] [Related]
17. Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells. Waeckerle-Men Y; Allmen EU; Gander B; Scandella E; Schlosser E; Schmidtke G; Merkle HP; Groettrup M Vaccine; 2006 Mar; 24(11):1847-57. PubMed ID: 16288821 [TBL] [Abstract][Full Text] [Related]
18. Use of a liposome antigen delivery system to alter immune responses in vivo. Lutsiak CM; Sosnowski DL; Wishart DS; Kwon GS; Samuel J J Pharm Sci; 1998 Nov; 87(11):1428-32. PubMed ID: 9811501 [TBL] [Abstract][Full Text] [Related]
19. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation. Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of PEGylated exendin-4 released from poly (lactic-co-glycolic acid) microspheres for antidiabetic therapy. Lim SM; Eom HN; Jiang HH; Sohn M; Lee KC J Pharm Sci; 2015 Jan; 104(1):72-80. PubMed ID: 25407390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]